Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for a most interesting post. It appears the path forward for Ipix is getting wider by the day.
You make a good point. I do think that as the trial progresses the sp will start to increase for the fear of being left out.
It was judged to be safe to go to five day dosing. That imo was not a surprise.
And hopefully shareholders too.
Going to administering Brilacidin from three days to five days gives the drug more time to work against the virus which is a better outcome for the company.
Silence could be golden as Brilacidin works its magic in a clinical trial
He talked about borrowed shares which means the “short” position is probably perfectly legal. It basically was a lot of crap spoken and not worth listening too. Sorry!
I assume your post has nothing to do with the preceding post to yours!
It is perfectly permissible to be bullish on Ipix and is an incredible achievement to have Brilacidin in a clinical trial. Successful results could lead to 10 times the sp and be the start of a new chapter for the company.
With so many indications of potential success I believe we are more likely to break to the upside than the other way round.
Don’t care where the sites are we needed to get Brilacidin into a trial. There would be no road forward without it.
I think there was an attempt to negate any possible “good” news by driving the stock down and lessening the impact of an announcement. Guess what, it didn’t work.
None of this matters with a successful trial and none of the old news will matter either.
I bought some at 28 cents so I at least put my money where my mouth is.
Thanks to RBL testing I think we have better odds of succeeding than failing.I am looking for the excitement pendulum to take us as high as $10 if we succeed. And if we do succeed Brilacidin will be known the world over.
Agree, my comment was too broad brushed and there are definitely people one can learn a lot from on this board.
Looking forward to the day Brilacidin successes are the only topic on here.
Fully agree Jhawker there is an absolute need for a therapeutic especially one that can not only treat COVID-19 but also common viruses. Before I got my two vaccine shots I was desperate for a therapeutic to be on hand and I still think that applies to a lot of the world right now.
Your doggedness should really have paid off for you. Congratulations!
AI is playing a big part in medicine and many different industries today but you have to have i to understand that.
Perhaps this news makes it a little easier for Big Pharma to take a more serious look at Ipix.
Are all the compounds in clinical trials?
There’s your news and it’s a glorious day.
I don’t think a tingle in the big toe is going to stop a drug that cures COVID-19. Before you go nuts I did not say Brilacidin.
I don’t mind being corrected but if they extend it it is only for those who are about to receive their 3 day dose but now extended to 5. Is that right? In other words it doesn’t include trialists who have already received their dosage of 3 days. Thanks.
I assumed it would be on a case by case basis after three days as to extend or not due to signs of progress.
Hey Pete I have given up thinking anything fast or urgent is going to happen pandemic et all. I thought we would get a grant but that hasn’t happened but I am happy we are in a trial and let’s face it a therapeutic is desperately needed now and in the future. Unfortunately we will have to put up with the screamers for a while longer.
Slow is better you don’t want to blow yourselves out of the water because you hurried a trial. Geez Louise.
Absolutely right.
Let’s hope Brilacidin trial results can substantiate we have a major drug franchise and push the stock price up enough we don’t have to resort to toxic financing ever again.
Reference to the Cell Culture journal
Don’t see that anywhere.
Tremendous news in case you don’t know is Ipix has two trials going, one in the US and one in Russia. It takes away from all the stuff that seems to bother you and refocuses us on the prize of what it means to show Brilacidin as an effective therapeutic.
I’ve come on the board and read your post which I truly agree with. If people were looking for the legitimacy of Brilacidin then this is it and everybody can make their own decisions as to what to do with it. Looks really solid to me.
Thank you for the explanation. It had me very concerned as unfortunately unless it is simply put I fail to grasp all the information and then become suspicious of the intent of the poster.
Thanks farrell90 your comments are most welcome.
And the moon is made of cheese.
So if Leo wants to raise more money he can offer shareholders convertible warrants. I’d go for them wouldn’t you?
Talking to myself in the shower this morning I told myself that Brilacidin is such a big drug I have to hold through this bad patch. Three different modes of action pointing towards major diseases convinces me that the magic $ land is highly possible.
You might like to but you don’t get that option.